Format

Send to

Choose Destination
World J Surg. 2016 Oct;40(10):2441-50. doi: 10.1007/s00268-016-3582-2.

Cost-Benefit Analysis of the Implementation of an Enhanced Recovery Program in Liver Surgery.

Author information

1
Department of Visceral Surgery, University Hospital of Lausanne (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland.
2
Department of Anesthesiology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
3
Medical Directorate, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
4
Department of Visceral Surgery, University Hospital of Lausanne (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland. demartines@chuv.ch.

Abstract

BACKGROUND:

Enhanced recovery after surgery (ERAS) programs have been shown to ease the postoperative recovery and improve clinical outcomes for various surgery types. ERAS cost-effectiveness was demonstrated for colorectal surgery but not for liver surgery. The present study aim was to analyze the implementation costs and benefits of a specific ERAS program in liver surgery.

METHODS:

A dedicated ERAS protocol for liver surgery was implemented in our department in July 2013. The subsequent year all consecutive patients undergoing liver surgery were treated according to this protocol (ERAS group). They were compared in terms of real in-hospital costs with a patient series before ERAS implementation (pre-ERAS group). Mean costs per patient were compared with a bootstrap T test. A cost-minimization analysis was performed.

RESULTS:

Seventy-four ERAS patients were compared with 100 pre-ERAS patients. There were no significant pre- and intraoperative differences between the two groups, except for the laparoscopy number (n = 18 ERAS, n = 9 pre-ERAS, p = 0.010). Overall postoperative complications were observed in 36 (49 %) and 64 patients (64 %) in the ERAS and pre-ERAS groups, respectively (p = 0.046). The median length of stay was significantly shorter for the ERAS group (8 vs. 10 days, p = 0.006). The total mean costs per patient were €38,726 and €42,356 for ERAS and pre-ERAS (p = 0.467). The cost-minimization analysis showed a total mean cost reduction of €3080 per patient after ERAS implementation.

CONCLUSIONS:

ERAS implementation for liver surgery induced a non-significant decrease in cost compared to standard care. Significant decreased complication rate and hospital stay were observed in the ERAS group.

PMID:
27283186
DOI:
10.1007/s00268-016-3582-2
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Springer Icon for University of Lausanne/CHUV - Serval
Loading ...
Support Center